not tagged
CRISPR therapeutics AG
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)']
#eha22 #leusm schmoellerl: evi1 (mecom locus) rearranged in ~2% aml and assoc with adverse prognosis. mechanism if leukemogenesis not fully understood. crispr screen in cell line with evi1/mecom dependence implicated erg dependence. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)